From News Nation:
“FDA advisory panel endorses Pfizer
booster shots, but not for everyone”
A panel of expert outside
advisers to the U.S. Food and Drug Administration voted against approving
COVID-19 booster shots for most Americans, but it endorsed the extra shots for
those who are 65 or older or run a high risk of severe disease. The panel voted
16-2 against approving boosters for Americans age 16 and older. The twin votes
Friday potentially undermine the Biden administration’s plan to roll out third
shots of the Pfizer/BioNTech vaccine as soon as next week.
Then, in an 18-0 vote, it
endorsed the extra shot for select portions of the U.S. population — namely,
those most at risk from the virus. Over several hours of discussion, members of
the FDA panel voiced frustration that Pfizer had provided little data on the
safety of extra doses. Many committee members were critical of the booster
plan, arguing that the data presented by Pfizer and the FDA is incomplete and
that the request for approval for people as young 16 years old is too broad.
Most of them said they would support boosters for older Americans, but did not
think they were needed yet for younger adults. Top FDA members have been split
on the necessity of the boosters, with interim head Janet Woodcock backing them
and some of the agency’s top scientists arguing they are not needed yet. This
panel is not the deciding body. The FDA can go against the recommendation they
provide.
If the FDA approves the booster,
a separate panel advising the U.S. Centers for Disease Control and Prevention
will meet next week to recommend which groups should get them. The White House
said it was ready to roll out boosters next week if health officials approve
the plan.
^ It seems the majority of Americans
won’t be getting a Booster anytime soon. ^
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.